Valuation UCB

Stocks

Market Closed - Euronext Bruxelles Other stock markets 19:55:00 10/07/2026 +04			5-day change	1st Jan Change
237.10 ^EUR	-5.16%		-8.63%	-0.63%

07-09	UK Life Sciences Hits GBP3 Billion Investment Milestone	MT
07-03	Berenberg Updates Price Target, Estimates for UCB on Recent Pipeline Deals	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,947	13,973	14,969	36,464	45,333	45,135	-	-
Change	-	-26.25%	7.12%	143.6%	24.32%	-0.44%	-	-
Enterprise Value (EV) ¹	19,807	15,973	17,146	37,918	45,326	44,863	42,822	40,288
Change	-	-19.36%	7.34%	121.15%	19.54%	-1.02%	-4.55%	-5.92%
P/E	17.9x	33.4x	44.8x	34.3x	29.1x	25.6x	20.2x	16.2x
PBR	2.32x	1.58x	1.67x	3.64x	-	3.84x	3.3x	2.72x
PEG	-	-0.6x	-2.2x	0x	0.6x	2x	0.8x	0.7x
Capitalization / Revenue	3.28x	2.53x	2.85x	5.93x	5.86x	5.29x	4.68x	4.2x
EV / Revenue	3.43x	2.9x	3.26x	6.16x	5.86x	5.26x	4.44x	3.75x
EV / EBITDA	12.1x	12.7x	12.7x	25.7x	17.2x	15.4x	11.9x	9.42x
EV / EBIT	15x	23.7x	26.1x	45.4x	22.6x	19.2x	14.5x	11x
EV / FCF	15.6x	18.4x	38.5x	41.2x	24.6x	23x	16.5x	12.9x
FCF Yield	6.42%	5.43%	2.6%	2.43%	4.06%	4.35%	6.05%	7.75%
Dividend per Share ²	1.3	1.33	1.36	1.39	1.45	1.465	1.505	1.538
Rate of return	1.3%	1.81%	1.72%	0.72%	0.61%	0.62%	0.63%	0.65%
EPS ²	5.6	2.2	1.76	5.61	8.2	9.254	11.74	14.66
Distribution rate	23.2%	60.5%	77.3%	24.8%	17.7%	15.8%	12.8%	10.5%
Net sales ¹	5,777	5,517	5,252	6,152	7,741	8,534	9,635	10,747
EBITDA ¹	1,641	1,260	1,349	1,476	2,636	2,907	3,599	4,278
EBIT ¹	1,318	675	657	836	2,009	2,331	2,948	3,664
Net income ¹	1,058	418	343	1,065	1,558	1,751	2,274	2,834
Net Debt ¹	860	2,000	2,177	1,454	-7	-271.3	-2,313	-4,846
Reference price ²	100.35	73.56	78.90	192.20	238.60	237.10	237.10	237.10
Nbr of stocks (in thousands)	188,812	189,959	189,721	189,720	189,996	190,361	-	-
Announcement Date	24/02/22	22/02/23	28/02/24	27/02/25	24/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
UCB	25.62x	5.26x	15.43x	0.62%	51.6B
REGENERON PHARMACEUTICALS, INC.	17.23x	3.77x	10.12x	0.59%	67.61B
SAMSUNG BIOLOGICS CO.,LTD.	34.6x	11.72x	22.41x	-.--%	43B
CSL LIMITED	-46.01x	3.23x	9.56x	3.34%	40.94B
BIOGEN INC.	30.35x	3.47x	10.97x	-.--%	29.4B
MODERNA, INC.	-7.88x	11.31x	-6.94x	-.--%	27.09B
INCYTE CORPORATION	37.89x	3.25x	9.81x	-.--%	23.32B
INNOVENT BIOLOGICS, INC.	62.11x	6.29x	41.57x	-.--%	19.89B
SWEDISH ORPHAN BIOVITRUM AB	26.16x	5.4x	14.45x	-.--%	16.91B
BRIDGEBIO PHARMA, INC.	-39.16x	18.25x	-55.41x	-.--%	16.84B
Average	14.09x	7.20x	7.20x	0.45%	33.66B
Weighted average by Cap.	13.88x	6.45x	9.91x	0.62%